Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Receives Average Recommendation of Moderate Buy from Analysts

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the seventeen brokerages that are currently covering the stock, MarketBeat.com reports. Seven investment analysts have rated the stock with a hold rating and ten have issued a buy rating on the company. The average 1-year price target among […]

Related Keywords

Canada , ,Institutional Investors Weigh In On Alnylam Pharmaceuticals ,Jpmorgan Chase Co ,Alnylam Pharmaceuticals ,Royal Bank ,Altitude Crest Partners Inc ,Nasdaq ,Alnylam Pharmaceuticals Stock Performance ,Alnylam Pharmaceuticals Inc ,Wolfe Research ,News Ratings For Alnylam Pharmaceuticals Daily ,Allspring Global Investments Holdings ,Analyst Recommendations For Alnylam Pharmaceuticals ,Investment Management ,Quent Capital ,Get Free Report ,Global Investments Holdings ,Crest Partners ,Get Free ,Alnylam Pharmaceuticals Daily ,